Arecor Therapeutics plc (LON:AREC – Get Free Report) reached a new 52-week low during trading on Wednesday . The stock traded as low as GBX 48 ($0.62) and last traded at GBX 48 ($0.62), with a volume of 264564 shares trading hands. The stock had previously closed at GBX 50.50 ($0.65).
Arecor Therapeutics Price Performance
The stock has a market cap of £19.78 million, a P/E ratio of -1.85 and a beta of -0.18. The company has a 50 day simple moving average of GBX 58.53 and a 200 day simple moving average of GBX 69. The company has a current ratio of 1.37, a quick ratio of 6.24 and a debt-to-equity ratio of 5.51.
Arecor Therapeutics Company Profile
Arecor Therapeutics plc is a globally focused biopharmaceutical company transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying our innovative proprietary technology platform, Arestat™, we are developing an internal portfolio of proprietary products in diabetes and other indications, as well as working with leading pharmaceutical and biotechnology companies to deliver therapeutic products.
Featured Stories
- Five stocks we like better than Arecor Therapeutics
- Roth IRA Calculator: Calculate Your Potential Returns
- Is Myers Industries Poised for a Breakout?
- Stock Splits, Do They Really Impact Investors?
- Is BigBear.ai’s 25% Plunge a False Alarm or Fire Sale?
- Short Selling: How to Short a Stock
- Broadcom Confirmed Its AI Outlook: Stock to Hit New Highs Soon
Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
